We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+16.51%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
-$485M
(-20%)
Cap. Flow
-$562M
Cap. Flow
% of AUM
-29.17%
Top 10 Holdings %
Top 10 Hldgs %
5.51%
Holding
3,496
New
1,220
Increased
551
Reduced
717
Closed
1,006
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$10.4M |
| 2 |
Cisco
CSCO
|
+$7.97M |
| 3 |
American Tower
AMT
|
+$7.79M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$7.33M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$16.2M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$15.1M |
| 3 |
Amazon
AMZN
|
+$13.7M |
| 4 |
Philip Morris
PM
|
+$13.5M |
| 5 |
Amphenol
APH
|
+$12.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14% |
| 3 | Healthcare | 12.51% |
| 4 | Consumer Discretionary | 11.31% |
| 5 | Industrials | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Nephros
NEPH
$36.7M
| $68.8K | ﹤0.01% |
+14,555
| New | +$57.2K |
|
2102
The ONE Group
STKS
$55.6M
| $68.3K | ﹤0.01% |
+23,084
| New | +$72.4K |
|
2103
Roma Green Finance Ltd
ROMA
$534M
| $68.2K | ﹤0.01% |
+23,448
| New | +$71.5K |
|
2104
Accuray
ARAY
$28.7M
| $67K | ﹤0.01% |
+40,111
| New | +$59.3K |
|
2105
Information Services Group
III
$203M
| $66.5K | ﹤0.01% |
+11,568
| New | +$57.5K |
|
|
KAZR
2106
Skyline Builders Group
KAZR
$42.6M
| $65.7K | ﹤0.01% |
+19,200
| New | +$37.5K |
|
|
HYFT
2107
MindWalk Holdings
HYFT
$63.1M
| $65.4K | ﹤0.01% |
37,390
-53,992
| -59% | -$106K |
|
|
YQ
2108
17 Education & Technology Group
YQ
$19.6M
| $65.4K | ﹤0.01% |
15,277
+3,817
| +33% | +$9.34K |
|
2109
WidePoint Corp
WYY
$101M
| $65.4K | ﹤0.01% |
13,218
-3,771
| -22% | -$15.3K |
|
|
MTLS
2110
Materialise
MTLS
$371M
| $65.1K | ﹤0.01% |
+11,690
| New | +$62.6K |
|
2111
Acrivon Therapeutics
ACRV
$65.1M
| $65.1K | ﹤0.01% |
35,955
-70,164
| -66% | -$98.6K |
|
|
IOBT
2112
DELISTED
IO Biotech
IOBT
| $65.1K | ﹤0.01% |
179,207
+150,018
| +514% | +$259K |
|
2113
Identive
INVE
$63.1M
| $64.9K | ﹤0.01% |
18,822
+7,130
| +61% | +$25.5K |
|
|
SOL
2114
DELISTED
Emeren Group
SOL
| $64.9K | ﹤0.01% |
34,344
+10,591
| +45% | +$20K |
|
2115
Atea Pharmaceuticals
AVIR
$376M
| $64.6K | ﹤0.01% |
22,275
-64,849
| -74% | -$221K |
|
2116
PetMed Express
PETS
$43M
| $64.5K | ﹤0.01% |
+25,681
| New | +$79.4K |
|
|
EEX
2117
DELISTED
Emerald Holding
EEX
| $64.2K | ﹤0.01% |
12,615
-17,512
| -58% | -$88.4K |
|
2118
Xilio Therapeutics
XLO
$60.7M
| $64.1K | ﹤0.01% |
5,432
+2,952
| +119% | +$29.6K |
|
2119
Laird Superfood
LSF
$46.3M
| $64.1K | ﹤0.01% |
11,482
-4,765
| -29% | -$29.9K |
|
2120
Acacia Research
ACTG
$452M
| $63.7K | ﹤0.01% |
+19,590
| New | +$67.8K |
|
2121
Spero Therapeutics
SPRO
$68.9M
| $63.5K | ﹤0.01% |
33,801
-750
| -2% | -$1.65K |
|
2122
Nokia
NOK
$48.1B
| $63.4K | ﹤0.01% |
13,186
-108,019
| -89% | -$488K |
|
2123
Alto Neuroscience
ANRO
$1.07B
| $63.3K | ﹤0.01% |
+15,746
| New | +$52.2K |
|
2124
Oramed Pharmaceuticals
ORMP
$171M
| $63.1K | ﹤0.01% |
+23,885
| New | +$52.8K |
|
2125
Shattuck Labs
STTK
$651M
| $62.7K | ﹤0.01% |
+26,226
| New | +$32.1K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q3 2025 Portfolio in Review
As of Q3 2025, XTX Topco held 3,496 positions worth $1.93B, down 20% from $2.41B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco withdrew a net $562M in Q3 2025, closing 1,006 positions and reducing 717 holdings. Its most notable exit was T-Mobile US, an estimated $9.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, XTX Topco opened a new position in Johnson & Johnson worth $11.3M.
- XTX Topco's largest Q3 2025 buy was Johnson & Johnson: 60,929 shares worth $11.3M.
- XTX Topco added most to Invesco QQQ Trust in Q3 2025, an estimated $7.33M increase.
- XTX Topco's biggest Q3 2025 reduction was Oracle, cutting an estimated $16.2M.
- XTX Topco fully exited T-Mobile US in Q3 2025, selling an estimated $9.81M.
- XTX Topco's ten largest holdings make up 5.5% of its $1.93B portfolio in Q3 2025.
- XTX Topco opened 1,220 new positions and closed 1,006 in Q3 2025.
- XTX Topco's portfolio value fell 20% quarter-over-quarter to $1.93B.
Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.